Best Practices for Anterior Segment Ophthalmology Trials w/ Dr. Joseph Tauber

Dr. Joseph Tauber and Dr. George Magrath have participated in hundreds of ophthalmology clinical trials between them. They give tips and practical advice for anterior segment studies, including Dry Eye. They also discuss the advantages of a new modified NEI grading scale for corneal fluorescein staining.

Hear about the challenges in the approval process for ophthalmology drugs, how the world of clinical trials is changing, and what to expect in the future for vision care and clinical studies.

Joseph Tauber, M.D., specializes in anterior segment surgery, corneal transplantation, the treatment of corneal and external diseases and laser vision correction procedures. A board-certified ophthalmologist, Dr. Tauber received his doctorate from Harvard Medical School, his training in internal medicine at Beth Israel Hospital and in ophthalmology at Tufts-New England Medical Center, all located in Boston, Massachusetts. Dr. Tauber enhanced his medical education with two years of ocular immunology and corneal and external disease fellowship training at the Massachusetts Eye and Ear Infirmary.

Dr. Tauber is an internationally recognized authority in the field of ocular surface diseases, including dry eye and meibomitis management. He has been a Principal Investigator in dozens of clinical research programs, including those that led to the approval of the only two medications approved by the FDA for the treatment of dry eye – Restasis and Xiidra.

Best Practices for Anterior Segment Ophthalmology Trials

George Magrath, M.D., is Chief Executive Officer of Lexitas Pharma Services and a practicing ophthalmologist, with extensive expertise in posterior and retina.